What factors drive anticoagulant reversal drugs market growth in the APAC?

Countries such as China and India are expected to lead the market.

The ageing population and the increasing prevalence of conditions like atrial fibrillation are driving significant growth in the anticoagulant reversal drugs market in the Asia Pacific, said Technavio.

Countries such as China and India are expected to lead the expansion due to enhanced healthcare infrastructure, government initiatives, and a growing number of generic drug manufacturers.

“India, for instance, has launched programmes to increase access to essential medications, including anticoagulant reversal drugs, in rural areas,” the report said.

On a global scale, the market is projected to rise by $1.27b by 2029 at a compound annual growth rate of $12.5%.

The sector’s expansion is attributed to the rising prevalence of coagulation disorders with a trend towards a growing focus on emerging economies.